Insider Trading History of Arkowitz David


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Arkowitz David since year 2005. The trader's CIK number is 1296999. At the time of the last reporting, Arkowitz David was the Chief Financial Officer of Flexion Therapeutics Inc . (stock ticker symbol FLXN). See this page for all insider trading activities at Flexion Therapeutics Inc .

Note that in the past Arkowitz David also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Arkowitz David since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-05-31 FLXN Flexion Therapeutics Inc Buy 2,500 11.05 27,627
2019-05-13 FLXN Flexion Therapeutics Inc Buy 4,000 11.99 47,960
2019-05-08 FLXN Flexion Therapeutics Inc Sale 2,248 10.06 22,614
2018-11-09 FLXN Flexion Therapeutics Inc Buy 4,000 16.55 66,220
2018-08-09 FLXN Flexion Therapeutics Inc Buy 4,000 23.42 93,680
2017-08-04 SBPH Spring Bank Pharmaceuticals, Inc. Buy 2,500 12.24 30,612
2011-05-31 AMAG Amag Pharmaceuticals Inc. Buy 1,500 13.23 19,845
2011-02-24 AMAG Amag Pharmaceuticals Inc. Sale 2,705 17.08 46,201
2010-08-05 AMAG Amag Pharmaceuticals Inc. Sale 15,750 .00 0
2010-05-28 AMAG Amag Pharmaceuticals Inc. Buy 658 27.06 17,805
2009-12-01 AMAG Amag Pharmaceuticals Inc. Buy 172 31.78 5,466
2009-06-02 AMAG Amag Pharmaceuticals Inc. Buy 529 25.61 13,547
2009-11-12 AMAG Amag Pharmaceuticals Inc. Sale 4,459 43.41 193,587
2008-06-11 AMAG Amag Pharmaceuticals Inc. Buy 1,000 37.50 37,500
2007-05-05 AMAG Amag Pharmaceuticals Inc. Buy 1,000 40.38 40,378

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Arkowitz David (Chief Financial Officer of Flexion Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.